home / stock / eryp / eryp news

ERYP News and Press, Erytech Pharma S.A. From 07/10/20

Stock Information
Company Name: Erytech Pharma S.A.
Stock Symbol: ERYP
Market: NASDAQ
Menu
ERYP ERYP Quote ERYP Short ERYP News ERYP Articles ERYP Message Board
Get ERYP Alerts

News, Short Squeeze, Breakout and More Instantly...
ERYP - Monthly information related to total number of voting rights and shares composing the share capital - June 30, 2020

LYON, France, July 10, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & ...
ERYP - ERYTECH Reports Voting Results from its Annual General Meeting Held on June 26, 2020

LYON, France and CAMBRIDGE, Mass., June 26, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP) announced that its 2020 Annual General Meeting was held in Lyon on Friday, June 26, 2020. At the meeting, all resolutions for which the Board of Directors recommended a...

ERYP - ERYTECH extends its cash horizon by implementing a convertible bond financing

LYON,France and CAMBRIDGE, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic substances in red blood cells, announced today the signature of an agr...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - May 30, 2020

LYON, France, June 09, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & N...
ERYP - ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia

Patient enrollment completed; 50 patients in the trial Encouraging preliminary results based on interim data Unmet medical need confirmed by FDA LYON, France and CAMBRIDGE, Mass., June 09, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage ...

ERYP - ERYTECH to Participate Fireside Chat at Jefferies Virtual Healthcare Conference

LYON, France and CAMBRIDGE, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil BEYEN...

ERYP - ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting

LYON, France and CAMBRIDGE, Mass., June 01, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announces the presentation ...
ERYP - ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2020 Results - Earnings Call Transcript

ERYTECH Pharma S.A. (ERYP) Q1 2020 Earnings Conference Call May 7, 2020 08:30 ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial Officer & Chief Operating Officer Iman El-Hariry - Chief Medical Officer Conference Call Participants F...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - April 30, 2020

LYON, France, May 07, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & ...

ERYP - Erytech Pharma reports Q1 cash position of Euro58.6M

Erytech Pharma (NASDAQ: ERYP ): Q1 Cash and equivalents of €58.6M More news on: ERYTECH Pharma S.A., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10